​Join BioLabs to discuss how to avoid the biotech valley of death and fundraise successfully!

​Explore strategies for navigating the transition from Seed to Series A funding, avoiding common startup pitfalls, and positioning biotech companies for long-term growth, partnerships, and investment. Hear from the biotech and investor perspective in the US and Canada.

​Panelists

​Parimal Nathwani, Managing Partner, Life Sciences Fund, BDC

​Daniel Durocher​, Co-Founder, Induxion Therapeutics

​Jennifer Griffin​, Partner, Strategy & Investor Relations, Mission BioCapital

​Cory Sago​, CEO/Founder, Amplitude Therapeutics

​Moderated by Jennifer Fraser​, Director of Innovation, University of Toronto

​What to Expect:

​5:00–5:30 PM – Registration & Networking

​5:30–6:30 PM – Panel Discussion

​6:30–8:00 PM – Networking Reception

​8:00 PM – Event Conclusion

​Space is limited, reserve your spot today!